Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 5/2018

01-10-2018 | Correction

Correction to: A systematic review of patient perspectives on surveillance after colorectal cancer treatment

Authors: Julia R. Berian, Amanda Cuddy, Amanda B. Francescatti, Linda O’Dwyer, Y. Nancy You, Robert J. Volk, George J. Chang

Published in: Journal of Cancer Survivorship | Issue 5/2018

Login to get access

Excerpt

Correction to: J Cancer Surviv (2017) 11:542–552 …
Appendix
Available only for authorised users
Metadata
Title
Correction to: A systematic review of patient perspectives on surveillance after colorectal cancer treatment
Authors
Julia R. Berian
Amanda Cuddy
Amanda B. Francescatti
Linda O’Dwyer
Y. Nancy You
Robert J. Volk
George J. Chang
Publication date
01-10-2018
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 5/2018
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-018-0698-4

Other articles of this Issue 5/2018

Journal of Cancer Survivorship 5/2018 Go to the issue

OriginalPaper

Potential determinants of physical inactivity among long-term colorectal cancer survivors

OriginalPaper

Impact of acculturation on breast cancer treatment and survivorship care among Mexican American patients in Texas

OriginalPaper

Creation and evaluation of a cancer survivorship curriculum for pediatric resident physicians

OriginalPaper

Insurance, chronic health conditions, and utilization of primary and specialty outpatient services: a Childhood Cancer Survivor Study report

OriginalPaper

Long-term survivors of childhood cancer: cure and care—the Erice Statement (2006) revised after 10 years (2016)

OriginalPaper

Reproductive and gynecological complication risks among thyroid cancer survivors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits